Perceive Pharma

Developer of small molecule neuroprotective therapeutics designed for targeting glaucoma and other ophthalmic diseases. The company's platform leverages retina cell screening to identify neuroprotecti...

Healthcare
San Francisco, CA, United States
Valuation
$50M
Market implied
Share Price
N/A
Total Raised
$19.5M
Last Round
N/A

Get the full picture

Create a free account to unlock Perceive Pharma's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required